ライフサイエンスコーパス: diastolic

1 deling at 6 months included decreases in end-diastolic (161 +/- 36 ml to 122 +/- 30 ml; p < 0.001) an

2 95% confidence interval [CI], 2.64-6.51) and diastolic (2.25 mm Hg; 95% CI, 0.83-3.67) blood pressure

3 Seventeen patients (71%) had diastolic abnormalities, and 7 patients (29%) met the de

4 arts revealed that all LV parameters (LV end-diastolic and -systolic dimensions, ejection fraction, a

5 Left ventricular structure, diastolic and contractile function, and ventricular-arte

6 se training reverses age-induced declines in diastolic and coronary microvascular function.

7 Although we observed worse diastolic and longitudinal function with advanced age or

8 Thus, age-related diastolic and microvascular dysfunction are reversed by

9 -life exercise training reverses age-related diastolic and microvascular dysfunction.

10 ted at an advanced age, reverses age-related diastolic and microvascular dysfunction; these data sugg

11 Impaired diastolic and systolic cardiac function was observed in

12 The method yielded central systolic, diastolic, and pulse pressure bias and precision errors

13 9%, 2.5%, and 3.1% of variation in systolic, diastolic, and pulse pressure, respectively, in GERA non

14 ciation study on long-term average systolic, diastolic, and pulse pressure.

15 sure control (<140 mm Hg systolic, <90 mm Hg diastolic), angiotensin-converting enzyme inhibitor or a

16 (peak ); and diastolic uncoupling (systolic -diastolic at same volume) during early diastole (UNCOUP_

17 tolic (SRs), early diastolic (SRe), and late diastolic atrial contraction phases (SRa) were analyzed

18 ovel index AI rd , a combination of AI r and diastolic augmentation index (AI d ) with a weight alpha

19 tenth percentile and absent or reversed end-diastolic blood flow in the umbilical artery on Doppler

20 ned as systolic blood pressure >/=140 mm Hg, diastolic blood pressure >/=90 mm Hg, or initiation of a

21 e medications while maintaining systolic and diastolic blood pressure <140 mm Hg and 90 mm Hg, respec

22 CI, -1.77 to -0.75]; 22 trials [n = 57953]), diastolic blood pressure (-0.49 mm Hg [95% CI, -0.82 to

23 the definition of hypertension, systolic and diastolic blood pressure (BP) thresholds for initiation

24 s were similar for each 10 mmHg increment in diastolic blood pressure (DBP) (p < 0.001) or each 15 mm

25 al in both systolic blood pressure (SBP) and diastolic blood pressure (DBP) between the magnesium-sup

26 (GL) with systolic blood pressure (SBP) and diastolic blood pressure (DBP) in healthy individuals.A

27 By contrast, a baseline diastolic blood pressure (DBP) less than 70 mm Hg was as

28 g or greater and less than 180 mm Hg, office diastolic blood pressure (DBP) of 90 mm Hg or greater, a

29 The change in diastolic blood pressure (DBP) over time was significant

30 The mean diastolic blood pressure (DBP) was lower in men with ast

31 Results for diastolic blood pressure (dBP) were similar.

32 e age of 7 y, systolic blood pressure (SBP), diastolic blood pressure (DBP), and the prevalence of ch

33 In individuals with a low diastolic blood pressure (DBP), the potential benefits o

34 io (WHtR), systolic blood pressure (SBP) and diastolic blood pressure (DBP).

35 Diastolic blood pressure (OR, 0.74; 95% CI, 0.65-0.84, p

36 .34; 95% CI: 1.05, 1.70), and new-onset high diastolic blood pressure (OR: 1.25; 95% CI: 0.99, 1.58)

37 EVA biomarkers included systolic and diastolic blood pressure (SBP and DBP), central pulse pr

38 ents occur among US adults with systolic and diastolic blood pressure (SBP/DBP) >/=140/90 mm Hg.

39 ; 15 trials, 1190 participants), and diurnal diastolic blood pressure (WMD, -1.3 points [95% CI, -2.2

40 otoxin, resiniferatoxin, selectively lowered diastolic blood pressure both at daytime and night-time

41 with acute respiratory infection and reduced diastolic blood pressure but not with other health measu

42 fferent neurotoxin, RTX, selectively lowered diastolic blood pressure CHF rats.

43 Outcomes included systolic and diastolic blood pressure from the average of 3 measures

44 d mean baseline office and 24-h systolic and diastolic blood pressure levels were 154 (14)/90 (11) mm

45 individuals provided 1,342,814 systolic and diastolic blood pressure measurements for a genome-wide

46 lic blood pressure of at least 140 mm Hg, or diastolic blood pressure of at least 90 mm Hg, or self-r

47 blood pressure 160 vs 110 mm Hg) but not for diastolic blood pressure or lipid measures with VTE.

48 average rate of change in both systolic and diastolic blood pressure was greater among African-Ameri

49 6 months (p=0.0003 for systolic and p=0.0001 diastolic blood pressure).

50 7-16) at 6 months (p<0.0001 for systolic and diastolic blood pressure).

51 Retirement was accompanied by a reduction in diastolic blood pressure, a slowdown in the increase of

52 r plasma CHGA levels, plasma glucose levels, diastolic blood pressure, and body mass index.

53 ensity lipoprotein cholesterol, systolic and diastolic blood pressure, and fasting glucose were measu

54 in biological (body-mass index, systolic and diastolic blood pressure, and handgrip strength), behavi

55 icant increases were detected in systolic or diastolic blood pressure, and no heterogeneity was obser

56 , triglycerides, fat mass (FM), systolic and diastolic blood pressure, fasting insulin and glucose, a

57 ht cardiometabolic traits (BMI, systolic and diastolic blood pressure, LDL cholesterol, HDL cholester

58 ociated with self-reported IHD, systolic and diastolic blood pressure, low-density lipoprotein- and t

59 d several cis-eGenes (ALDH2 for systolic and diastolic blood pressure, MCM6 and DARS for total choles

60 mbers of patients treated per center, higher diastolic blood pressure, off-hour admission, and absenc

61 5% CI: 0.86, 1.39 for new-onset systolic and diastolic blood pressure, respectively).

62 n the average rate of change in systolic and diastolic blood pressure, respectively, whereas family S

63 tation (nitric oxide, rho = -0.66, P = 0.06; diastolic blood pressure, rho = 0.68, P = 0.04) and infl

64 ngestive heart failure, warfarin, age, race, diastolic blood pressure, stroke), and observed that all

65 status, postmenopausal hormone therapy use, diastolic blood pressure, total cholesterol, high-densit

66 ween retirement and systolic blood pressure, diastolic blood pressure, waist circumference, body mass

67 % CI, -5.6 to -2.5; 6 studies; I2 = 17%) for diastolic blood pressure.

68 glycerides, HDL-c, glucose, and systolic and diastolic blood pressure.

69 o HDL cholesterol (TC:HDL), and systolic and diastolic blood pressures (SBP and DBP, respectively)].

70 , we found significantly higher systolic and diastolic blood pressures among those who entered or con

71 mentation significantly reduced systolic and diastolic blood pressures, cardiac fibrosis, and left ve

72 40 to 79 years of age, with clinic systolic/diastolic BP <140/90 mm Hg, who completed ambulatory BP

73 : -2.14, 0.06) and a 0.63-mm Hg decrement in diastolic BP (95% CI: -1.35, 0.09), controlling for sex,

74 tory hypertension (daytime systolic BP [SBP]/diastolic BP [DBP] >/=135/85 mm Hg, 24-hour SBP/DBP >/=1

75 ciated with BP (P<10(-320)) for systolic and diastolic BP and CVD events regardless of the underlying

76 utcomes were the differences in systolic and diastolic BP changes from baseline to the end of follow-

77 Diastolic BP decreased by 12.2 mm Hg (95% CI, 11.2-13.2

78 upper tail of the systolic (except boys) and diastolic BP distribution shifted downwards, whereas the

79 ystolic BP and from the 92.9th to 98.9th for diastolic BP in the reconstructed population.

80 for association analysis with systolic BP or diastolic BP or pulse pressure.

81 ctively, Delta systolic BP P=3x10(-4), Delta diastolic BP P=5x10(-5)).

82 Regarding BP, systolic and diastolic BP presented similar partterns: the lower the

83 e black; mean age was 48 years, and mean SBP/diastolic BP was 135/86 mm Hg.

84 uction in sodium in drinking water, systolic/diastolic BP was lower on average by 0.95/0.57 mmHg, and

85 cross-sectional associations of systolic and diastolic BP with blood-derived genome-wide DNA methylat

86 2002 to 2005 and increased slightly to 2014, diastolic BP z-score decreased slightly from 1999 to 200

87 uggesting that older age, black race, higher diastolic BP, and higher lipids were associated with gre

88 ractions with age, baseline systolic BP, and diastolic BP, and the SAE model had 8 variables includin

89 e matched 1:2 by age, race, body mass index, diastolic BP, parity, and diabetes status, r-AKI remaine

90 he interindividual variation in systolic and diastolic BP, respectively.

91 val, 0.663-0.744) for clinic systolic BP and diastolic BP.

92 versus noncarriers (Delta systolic BP/Delta diastolic BP: -12.3/-8.2 versus -6.8/-3.5 mm Hg, respect

93 onger transient decay stabilize integrals of diastolic Ca and NCX current signals.

94 ) and isoproterenol (0.25 mumol/L) to induce diastolic Ca waves and subthreshold DADs.

95 as the principal regulators of systolic and diastolic Ca(2+) , respectively.

96 as the principal regulators of systolic and diastolic Ca(2+) , respectively.

97 tions characterized by abnormal increases in diastolic Ca(2+) .

98 y diminished, while the capacity to maintain diastolic Ca(2+) is moderately increased.

99 Increased diastolic Ca(2+) release in wt-PMI cardiomyocytes was re

100 aused a reduction of AP duration and reduced diastolic Ca(2+) spark rate.

101 which had increased amplitude compared with diastolic Ca(2+) sparks.

102 tivity of systolic Ca(2+) to LCC density and diastolic Ca(2+) to SERCA density decreased by 16-fold a

103 The factors responsible for regulation of diastolic [Ca(2+) ]i , in particular the relative roles

104 ecreasing Ca influx) will therefore increase diastolic [Ca(2+) ]i .

105 Increasing stimulation frequency increased diastolic [Ca(2+) ]i .

106 plitude of the systolic Ca transient control diastolic [Ca(2+) ]i .

107 plitude of the systolic Ca transient control diastolic [Ca(2+) ]i .

108 We conclude that diastolic [Ca(2+) ]i is controlled by the balance betwee

109 We show that diastolic [Ca(2+) ]i is increased by manoeuvres that dec

110 The increase of diastolic [Ca(2+) ]i produced by interfering with the SR

111 rs, mitochondria, Ca leak, and regulation of diastolic [Ca(2+)]i.

112 , which showed reduced mobility with altered diastolic conformation.

113 Apamin also slowed diastolic depolarization and reduced pacemaker rate in i

114 ssue, resulting in a decrease in the rate of diastolic depolarization and, consequently, the heart ra

115 rmination of the threshold potential and the diastolic depolarization rate that is independent of the

116 change of the membrane potential such as the diastolic depolarization rate.

117 HIIT and MCT (P=0.45); left ventricular end-diastolic diameter changes compared with RRE were -2.8 m

118 Change in left ventricular end-diastolic diameter from baseline to 12 weeks was not dif

119 comparison of change in left ventricular end-diastolic diameter from baseline to 12 weeks.

120 d smaller LV cavity, higher ratio of LVWT to diastolic diameter, and higher echocardiographic LV ejec

121 electrocardiography; decreased LV systolic, diastolic diameter, or septal E' velocity; higher ratio

122 septal E' velocity; higher ratio of LVWT to diastolic diameter; serum troponin level; and natriureti

123 en with preeclampsia had smaller mean LV end-diastolic diameters (5.2 versus 6.0 cm; P=0.001), greate

124 versus -9.06+/-3.89, P<0.001) and lower end-diastolic dimension z scores (4.12+/-2.61 versus 4.91+/-

125 ssed on measurements of left ventricular end-diastolic dimension, area, and volume.

126 239.9 vs. 576.7 +/- 472.9 events h(-1) ) and diastolic dysfunction (0.008 +/- 0.004 vs. 0.027 +/- 0.0

127 ventricular arrhythmic burden, and systolic/diastolic dysfunction (all p < 0.05).

128 Diastolic dysfunction (DD) is an independent predictor o

129 erved ejection fraction is often preceded by diastolic dysfunction (DD).

130 Twenty-three of them correlated with diastolic dysfunction (E/e') and 5 with left atrial volu

131 CV values (>/=0.40) were more likely to have diastolic dysfunction (P = .003) and increased left atri

132 Finally, Myr improved diastolic dysfunction and attenuated histological abnorm

133 )-related cardiomyopathy is characterized by diastolic dysfunction and hyperdynamic features.

134 ks of a high-salt diet, 31 of 38 rats showed diastolic dysfunction and preserved ejection fraction al

135 orubicin-injected fish developed ventricular diastolic dysfunction and worsening global cardiac funct

136 Increased left ventricular (LV) mass and diastolic dysfunction are associated with cardiovascular

137 Participants with diastolic dysfunction had higher ECV (0.49 +/- 0.07 vs 0

138 coronary perfusion are likely mechanisms of diastolic dysfunction in aged rats.

139 Late systolic load has been shown to cause diastolic dysfunction in animal models.

140 rdial fibrosis in SCA mice, but the cause of diastolic dysfunction in humans with SCA is unknown.

141 s a novel mechanism that appears to underlie diastolic dysfunction in SCA.

142 ABSTRACT: The risk for diastolic dysfunction increases with advancing age.

143 Incorporation of longitudinal strain and diastolic dysfunction into the Stage B definition reclas

144 Diastolic dysfunction is associated with microscopic myo

145 Diastolic dysfunction portends early mortality in SCA.

146 Diastolic dysfunction represents a combination of impair

147 y, smaller left atria, and less systolic and diastolic dysfunction than FG+ probands with HCM.

148 lar thickening at 4 weeks of age, as well as diastolic dysfunction that progressed with age, in Hyal2

149 ter, mean limb lead QRS voltage, and grade 3 diastolic dysfunction yielded excellent discriminatory c

150 ontributes to the development of age-related diastolic dysfunction, and (2) initiation of late-life e

151 iated feature of SCA that is associated with diastolic dysfunction, anemia, and high NT-proBNP.

152 normalities result in progressive and severe diastolic dysfunction, culminating in heart failure.

153 deformation indices with Doppler indices of diastolic dysfunction, functional capacity, biomarkers,

154 d ejection fraction and their correlation to diastolic dysfunction, functional class, pathophysiologi

155 uction, left ventricular hypercontractility, diastolic dysfunction, left-atrial enlargement and left

156 x and includes left ventricular systolic and diastolic dysfunction, pulmonary vascular disease, endot

157 ral chemoreflex pathway in HFpEF exacerbates diastolic dysfunction, worsens sympatho-vagal imbalance

158 d by nondilated left or right ventricle with diastolic dysfunction.

159 r pressure overload, leading to fibrosis and diastolic dysfunction.

160 s is related to changes in right ventricular diastolic dysfunction.

161 osolic calcium reuptake kinetics, indicating diastolic dysfunction.

162 , and 7 patients (29%) met the definition of diastolic dysfunction.

163 ion and contribution to cardiac fibrosis and diastolic dysfunction.

164 tion between diffuse myocardial fibrosis and diastolic dysfunction.

165 frequently associated with left ventricular diastolic dysfunction.

166 in both normal animals and a pig model with diastolic dysfunction.

167 g, sympatho-vagal imbalance, arrhythmias and diastolic dysfunction.

168 ats (SHAM) and aortic-banded rats exhibiting diastolic dysfunction.

169 nd E/e' ratios; 2) their roles in diagnosing diastolic dysfunction; 3) prognostic implications of abn

170 ar exercise training ameliorates age-related diastolic dysfunction; however, the underlying mechanism

171 iac remodeling and worse systolic strain and diastolic e' velocity.

172 Isovolumic relaxation time (IVRT), early diastolic filling (E/A), myocardial performance index (M

173 cardiac parameters, including reduced early diastolic filling rates as well as a higher prevalence o

174 r hypertension, E/A, a diagnostic measure of diastolic filling, decreases, and isovolumic relaxation

175 consequence of left heart anatomy and aid LV diastolic filling.

176 placentas displaying absent or reversed end-diastolic flow contained reduced myosin heavy chain, smo

177 tility index (PIa) and an estimator based on diastolic flow velocity (FVd).

178 ction fraction and longitudinal strain), and diastolic function (based on e', E/e', and left atrial v

179 ion = 49+/-10% versus 58+/-10%; P<0.001) and diastolic function (early relaxation velocity = 8.9+/-2.

180 tion = 52+/-11% versus 63+/-8%; P<0.001) and diastolic function (early relaxation velocity = 9.3+/-2.

181 ion (left ventricular ejection fraction), LV diastolic function (early relaxation velocity), and coro

182 in childhood was associated with LV mass and diastolic function after adjustment for conventional car

183 ce, should be considered when characterizing diastolic function and dysfunction.

184 d the rest of the echocardiogram to describe diastolic function and guide patient management.

185 The latter correlated with diastolic function and intercellular adhesion molecule 1

186 Left atrial (LA) size is a marker of diastolic function and is associated with atrial fibrill

187 LV diastolic function and longitudinal strain provide incre

188 With these limits, 46% had normal diastolic function and were at low risk of HF hospitaliz

189 h age-associated changes in left ventricular diastolic function are well recognized, limited data exi

190 erminus impacts heart function by depressing diastolic function at baseline and limiting systolic res

191 either useful or challenging when evaluating diastolic function clinically; and 5) their usefulness i

192 ograms were performed to assess systolic and diastolic function from 14 weeks of age.

193 ARIC-based limits for diastolic function improved risk discrimination over gui

194 imited data exist characterizing measures of diastolic function in older adults, including both refer

195 mplemented to improve coronary perfusion and diastolic function in the elderly.

196 of GSK-3beta, reduced fibrosis, and restored diastolic function in the mice that had experienced an A

197 How LBBB-related effects on LV diastolic function may contribute to those therapeutic f

198 prediction based on noninvasive measures of diastolic function may not be optimal.

199 dex 2.8+/-0.6 [1.9-3.9] L/min per m(2)), and diastolic function mildly abnormal.

200 ic remodeling and impairment of systolic and diastolic function parameters, whereas an increase in FF

201 ction traits (n = 32,212) and 17 cohorts for diastolic function traits (n = 21,852).

202 T1 measurements of blood and myocardium, and diastolic function was assessed by echocardiography.

203 Each measure of diastolic function was robustly associated with N-termin

204 ventricular (LV) morphology and systolic and diastolic function were evaluated with cardiac MRI and n

205 gen deposition and a decline in systolic and diastolic function were present only in WT mice, and not

206 s the relevant echocardiographic measures of diastolic function with blood-based biomarkers (such as

207 ic transmitral flow velocity (E/A) to assess diastolic function, and E to early diastolic mitral annu

208 42% of the study population as having normal diastolic function.

209 d with an increased impairment of myocardial diastolic function.

210 ventricular (LV) structure, and systolic and diastolic function.

211 .004) compared with participants with normal diastolic function.

212 known determinants of left ventricular (LV) diastolic function.

213 centric remodeling and improved systolic and diastolic functional variables.

214 d with the standard method of using only the diastolic gate.

215 hat Micu2(-/-) mice recapitulate features of diastolic heart disease and define previously unapprecia

216 ove Clinical Status and Exercise Capacity in Diastolic Heart Failure with Preserved Ejection Fraction

217 an earlier, more synchronized, and stronger diastolic LCR signal activating an earlier and larger in

218 did not affect blood pressure, systolic, or diastolic left ventricular function.

219 current (I f) and ryanodine receptor-derived diastolic local subsarcolemmal Ca(2+) release.

220 Irrespective of breath holding, LV end-diastolic mass was overestimated with SSIR (standard of

221 we determined the continuous association of diastolic measures (tissue Doppler imaging [TDI] e', E/e

222 pulation improves the risk discrimination of diastolic measures for incident HF or death.

223 ere at intermediate risk (2.4%/y), and all 3 diastolic measures were abnormal in 5% who were at high

224 to assess diastolic function, and E to early diastolic mitral annular tissue velocity (E/e') to estim

225 uch as thickness (hypertrophy) and function (diastolic or systolic), which lack mechanistic specifici

226 LV end-diastolic pressure (LVEDP) or the end-diastolic P-V relationship (EDPVR) in sham rats.

227 sociated with increased LV mass and impaired diastolic performance more than 3 decades later.

228 at spreads rapidly over the endocardium with diastolic periods between activations).

229 ion, membrane potentials such as the maximum diastolic potential, and rates of change of the membrane

230 =0.02) and more likely to have higher RV end-diastolic pressure (HR, 1.07; 95% CI, 1.00-1.15; P=0.057

231 paradoxically decreased left ventricular end-diastolic pressure (LVEDP) and left ventricular end-dias

232 astolic volumes with little effect on LV end-diastolic pressure (LVEDP) or the end-diastolic P-V rela

233 evidenced by increased left ventricular end-diastolic pressure and left ventricular volume indexes.

234 sure from randomization showed a benefit for diastolic pressure at month 12 (P = 0.039) but not at mo

235 Although left ventricular end-diastolic pressure decreased in 45/10, it increased in 4

236 The diastolic pressure difference (DPD) is recommended to di

237 section again blunted the increase in LV end-diastolic pressure secondary to volume expansion (+4+/-3

238 proach would mitigate the increase in LV end-diastolic pressure that develops during volume loading i

239 ericardiotomy blunted the increase in LV end-diastolic pressure with saline infusion, while enhancing

240 ction fraction [EF] and left ventricular end-diastolic pressure) was assessed at days 28 and 56.

241 velop increases in left ventricular (LV) end-diastolic pressures during exercise that contribute to d

242 re-volume loops were obtained to evaluate LV diastolic properties.

243 Diastolic pulmonary artery pressure and mean PAWP were m

244 sist devices (LVADs) has decoupling of their diastolic pulmonary artery pressure and pulmonary capill

245 to calculate the DPD as per usual practice (diastolic pulmonary artery pressure-mean PAWP).

246 QRS complex to calculate the QRS-gated DPD (diastolic pulmonary artery pressure-QRS-gated PAWP).

247 ents with Cpc-PH have severe PH, with higher diastolic pulmonary pressure gradient, transpulmonary pr

248 tic association of blood pressure (systolic, diastolic, pulse pressure) among UK Biobank participants

249 ad higher indexed right ventricular (RV) end-diastolic (range 85-326 mL/m(2), mean 148 mL/m(2)) volum

250 The systolic and diastolic rate constants also increased, while the diast

251 Liraglutide increased diastolic relaxation (dP/dt; Tau (1)/2; Tau (1)/e) durin

252 ccounting for altered contractility, reduced diastolic relaxation, and increased energy consumption,

253 h greater LV concentricity, lower myocardial diastolic relaxation, reduced global longitudinal strain

254 All diastolic resting indexes tested were identical to iFR,

255 The aim of this study was to compare other diastolic resting indexes to iFR.

256 the HAART-exposed group, LV mass and LV end-diastolic septal thickness were lower whereas LV contrac

257 adult feline ventricular myocytes increased diastolic spark rate and prolonged AP duration.

258 s in RyR2 activity in response to increasing diastolic SR [Ca(2+)] are influenced by CSQ2 and are dis

259 nd strain rate (SR) at systolic (SRs), early diastolic (SRe), and late diastolic atrial contraction p

260 interstitial collagen contribute to the high diastolic stiffness of failing myocardium.

261 , ECV was strongly correlated with the early diastolic strain rate (r = -0.782, p < 0.001) and modera

262 e BPnP amplitude increased linearly with the diastolic, systolic and mean BP.

263 displayed inotropic insufficiency, increased diastolic tension, and premature contractions; ranolazin

264 The results showed that XML reduced diastolic thickness of left ventricular posterior wall,

265 lic rate constants also increased, while the diastolic time constant decreased.

266 hermore, noise decreased from 0.105 (median, diastolic) to 0.042 (median, motion-corrected) (P = 0.02

267 phy guidelines recommend using early to late diastolic transmitral flow velocity (E/A) to assess dias

268 ole (Sslope); end-systolic peak (peak ); and diastolic uncoupling (systolic -diastolic at same volume

269 ral inflow velocity and mitral annular early diastolic velocity (E/e') ratio, had the highest left ve

270 reach statistical significance; however, the diastolic velocity-pressure gradient relation was consis

271 on in fractional shortening and an increased diastolic ventricular chamber size.

272 are cardiomyopathy characterized by impaired diastolic ventricular function resulting in a poor clini

273 ncing the saline-mediated increase in LV end-diastolic volume (+17+/-1 versus +10+/-2 mL; P=0.016).

274 significant decrease in left ventricular end-diastolic volume (-18 mL; P=0.009) and end-systolic volu

275 y associations with baseline and DeltaLV end diastolic volume (P<0.0001 for each) and not wall thickn

276 ic pressure (LVEDP) and left ventricular end-diastolic volume (preload) in CHF rats, which was not ob

277 ial lidocaine paradoxically decreased LV end-diastolic volume (preload) in CHF rats, which was not ob

278 ar events and a dilated LV (increased LV end-diastolic volume [EDV] indexed to body surface area) at

279 ated the progressive deterioration in LV end-diastolic volume and LV end-systolic volume.

280 s the change in indexed left ventricular end diastolic volume and LVEF.

281 During PEI, LV end-diastolic volume and stroke volume were increased in bot

282 167), and after replacing LV mass by LV end-diastolic volume in the regression models.

283 01), obesity (beta=1.3 mL/m(2), P<0.01), end-diastolic volume index (beta=0.4 mL/m(2), P<0.0001), Chi

284 a greater extent of LGE and a higher LV end-diastolic volume index than other groups, but levels of

285 tors (age, body mass index, diabetes, LV end-diastolic volume index, LGE, EF) (hazard ratio = 2.051 p

286 tic peptide, and larger left ventricular end-diastolic volume index.

287 olume index, and larger left ventricular end-diastolic volume index.

288 nd-systolic volumes (RVESVi) (indexed RV end-diastolic volume pPVR versus immediately after PVR versu

289 LA end-diastolic volume was increased in patients with mitral r

290 ions of RV mass and, to a lesser extent, end diastolic volume with PM10-2.5 mass among susceptible po

291 sed E-wave velocity and left ventricular end-diastolic volume, 2) exhibit a higher plasma volume, and

292 We quantified associations with RV mass, end-diastolic volume, and ejection fraction after control fo

293 ographic data, risk factors for scar, LV end-diastolic volume, and LV mass.

294 provements in LV end-systolic volume, LV end-diastolic volume, left ventricular ejection fraction, le

295 ncing the saline-mediated increase in LV end-diastolic volume.

296 : -4.3 [11.3] versus 7.4 [11.8], P=0.02; end-diastolic volume: -9.1 [14.9] versus 7.4 [15.8], P=0.02)

297 odeling (>20% change in left ventricular end-diastolic volume; 21.91 [2.75-174.29]; P=0.004).

298 n in CHF rats increased cardiac systolic and diastolic volumes and further increased the elevated LVE

299 ate and midterm reductions in indexed RV end-diastolic volumes and RV end-systolic volumes (RVESVi) (

300 decreased left ventricular (LV) systolic and diastolic volumes with little effect on LV end-diastolic